findmyKOL
Clinical trialNCT01147172CompletedInterventional

Safety Study of Cosmetic Tissue Augmentation in People of Color

SponsorAnika Therapeutics, Inc.Enrollment100Wrinkles
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Elevess is intended for all skin types. However, further study of all soft tissue fillers is needed in people of color because of the increasing use of cosmetic dermal filler products. This study is designed to evaluate the safety of an injectable hyaluronic acid based dermal filler Elevess (Anika Therapeutics, Inc., Bedford, MA). Safety will be evaluated by incidence and severity of keloid formation and pigmentation changes, and other potential adverse events in people with Fitzpatrick skin types IV, V and VI who have elected to undergo nasolabial fold (NLF) treatment with Elevess. 1\. Fitzpatrick Classification of Skin Type as: IV - Burns minimally, always tans well (moderate/light brown skin; Mediterranean, Asian, Hispanic. V - Rarely burns, tans profusely (dark brown/brown skin: Middle eastern, Latin, light skinned Black, Indian) VI - Never burns, (deeply pigmented dark brown to black skin;Black)

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Vitiligo and Pigmentation Inst of Southern California

    Los Angeles, California, United States

  • Skin Care Research, Inc.

    Boca Raton, Florida, United States

  • Dermatology Research Institute, Llc

    Coral Gables, Florida, United States

  • International Dermatology Research

    Miami, Florida, United States

  • William Coleman, Md

    Metairie, Louisiana, United States

  • Academic Dermatology Associates

    Albuquerque, New Mexico, United States

  • St Luke'S Roosevelt

    New York, New York, United States

  • Tenneesee Clinical Research Center

    Nashville, Tennessee, United States

  • Derm Research, Inc.

    Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2009
Primary completion
31 Dec 2009
Completion
31 Aug 2010
Last update posted
17 Oct 2017
Registered enrollment
100
Registry id
NCT01147172

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.